Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Amar, Kureishi"'
Autor:
John M Conly, Marianna Ofner-Agostini, Shirley Paton, Lynn Johnston, Michael Mulvey, Amar Kureishi, Lindsay Nicolle, Anne Matlow, the Canadian Hospital Epidemiology Committee, the Canadian Nosocomial Infection Surveillance Program
Publikováno v:
Canadian Journal of Infectious Diseases, Vol 12, Iss 6, Pp 364-370 (2001)
OBJECTIVE: To provide a rapid and efficient means of collecting descriptive epidemiological data on occurrences of vancomycin-resistant enterococcus (VRE) in Canada.
Externí odkaz:
https://doaj.org/article/96398fac98d84175865783bf8f4e961a
Autor:
Marianna Elisabeth Ofner-Agostini, John Conly, Shirley Paton, Amar Kureishi, Lindsay Nicolle, Michael Mulvey, Wendy Johnson, Lynn Johnston, the Canadian Hospital Epidemiology Committee
Publikováno v:
Canadian Journal of Infectious Diseases, Vol 8, Iss 2, Pp 73-78 (1997)
Externí odkaz:
https://doaj.org/article/c6262d2ee8bb4974bd876f09da5aa4c9
Publikováno v:
Canadian Journal of Infectious Diseases, Vol 7, Iss 3, Pp 209-212 (1996)
The most common sites of herpes simplex virus (HSV) infection are around the oral cavity and the genitalia. However, HSV can infect any skin or mucous membrane surface. One uncommon site of HSV infection is the breast. Reports of herpetic breast infe
Externí odkaz:
https://doaj.org/article/1f0a8e86aa214727840021f424d83aff
Autor:
Antoni, Torres, Javier, Garau, Pierre, Arvis, Jean, Carlet, Shurjeel, Choudhri, Amar, Kureishi, Marie-Aude, Le Berre, Hartmut, Lode, John, Winter, Robert C, Read, P, Petitpretz
Publikováno v:
Clinical Infectious Diseases. 46:1499-1509
The aim of this study was to show that sequential intravenous and oral moxifloxacin monotherapy (400 mg once per day) is as efficacious and safe as a combination regimen (intravenous ceftriaxone, 2 g once per day, plus sequential intravenous and oral
Publikováno v:
Journal of Antimicrobial Chemotherapy. 59:977-989
Objectives: To assess the cost-effectiveness of empirical outpatient treatment options for communityacquired pneumonia (CAP) in France, the USA and Germany, representing high, moderate and low antimicrobial resistance prevalence, respectively. Method
Autor:
Istvan Rakoczi, Jonathan D C Ross, Pierre Arvis, Tomasz Paszkowski, Peter Reimnitz, Amar Kureishi, Danguole Vildaite, Hendrik S Cronje, Melody Alefelder
Publikováno v:
Sexually Transmitted Infections. 82:446-451
Objective: This multinational, multicentre, prospective, randomised, double blind, parallel group, non-inferiority study compared the efficacy and safety of moxifloxacin monotherapy with ofloxacin plus metronidazole in women with uncomplicated pelvic
Autor:
N. Alfieri, Thomas J. Louie, F. P. Y. Laing, Amar Kureishi, Elizabeth Henderson, Ron Read, K. Ramotar
Publikováno v:
Journal of Clinical Microbiology. 33:513-518
Between April 1992 and December 1993, 80 Xanthomonas maltophilia isolates were collected from 63 patients in three acute-care hospitals in Calgary, Alberta, Canada. On the basis of Centers for Disease Control and Prevention definitions, 48 patients h
Publikováno v:
Antimicrobial Agents and Chemotherapy. 38:1944-1952
The Pseudomonas aeruginosa DNA gyrase gyrA gene was cloned and sequenced from strain PAO1. An open reading frame of 2,769 bp was found; it coded for a protein of 923 amino acids with an estimated molecular mass of 103 kDa. The derived amino acid sequ
Autor:
M Rubinger, Anthony W. Chow, Amar Kureishi, J A Smith, C D Cole, Donna E. Reece, Gordon L. Phillips, Peter J. Jewesson
Publikováno v:
Antimicrobial Agents and Chemotherapy. 35:2246-2252
A prospective, randomized, and double-blind study comparing teicoplanin with vancomycin in the initial management of febrile neutropenic patients was conducted. Teicoplanin was administered at 6 mg per kg of body weight every 24 h (q24h) intravenousl
Publikováno v:
Antimicrobial Agents and Chemotherapy. 34:1642-1647
Teicoplanin is a glycopeptide antibiotic with a mode of action and spectrum of activity similar to those of vancomycin. Its efficacy and tolerability as empiric therapy and its pharmacokinetic properties in neutropenic patients are being studied in a